pI: 6.7451 |
Length (AA): 882 |
MW (Da): 99853 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
9 | 63 | 2yc2 (A) | 13 | 64 | 33.00 | 0.0084 | 0.15 | 0.284958 | 0.4 |
9 | 88 | 1tvg (A) | 15 | 90 | 24.00 | 0.00017 | 0.11 | 0.187303 | 0.72 |
370 | 641 | 5jo8 (A) | 22 | 277 | 31.00 | 0 | 1 | 0.80149 | -1.5 |
370 | 643 | 5lph (A) | 416 | 673 | 33.00 | 0 | 1 | 0.797758 | -1.34 |
713 | 848 | 5lpi (D) | 743 | 875 | 45.00 | 0.00013 | 1 | 0.495795 | 0.46 |
722 | 847 | 5lpi (D) | 752 | 874 | 46.00 | 0 | 1 | 0.574957 | 0.25 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_130140)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_I002130 | hypothetical protein |
Drosophila melanogaster | Dmel_CG10137 | CG10137 gene product from transcript CG10137-RA |
Echinococcus granulosus | EgrG_000243550 | centrosomal protein of 104 kDa |
Echinococcus multilocularis | EmuJ_000243550 | hypothetical protein |
Giardia lamblia | GL50803_16818 | Glycine-, glutamate-, thienylcyclohexylpiperidine-binding protein |
Homo sapiens | ENSG00000116198 | centrosomal protein 104kDa |
Leishmania braziliensis | LbrM.19.0560 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_190240.1 | centrosomal protein of 104 kDa |
Leishmania infantum | LinJ.19.0240 | hypothetical protein, conserved |
Leishmania major | LmjF.19.0250 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.19.0250 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000039523 | centrosomal protein 104 |
Plasmodium yoelii | PY03720 | hypothetical protein |
Schistosoma mansoni | Smp_178710 | hypothetical protein |
Schmidtea mediterranea | mk4.024090.00 | Centrosomal protein of 104 kDa |
Schmidtea mediterranea | mk4.027941.00 | |
Schmidtea mediterranea | mk4.010847.01 | Centrosomal protein of 104 kDa |
Schmidtea mediterranea | mk4.027941.01 | Centrosomal protein of 104 kDa |
Schmidtea mediterranea | mk4.016121.03 | Centrosomal protein of 104 kDa |
Trypanosoma brucei gambiense | Tbg972.10.18050 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.14880 | centrosomal protein of 104 kDa |
Trypanosoma congolense | TcIL3000_10_12740 | centrosomal protein of 104 kDa |
Trypanosoma cruzi | TcCLB.511289.110 | centrosomal protein of 104 kDa |
Trypanosoma cruzi | TcCLB.506211.120 | centrosomal protein of 104 kDa |
Trichomonas vaginalis | TVAG_039890 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_462570 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_390050 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_471010 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_102530 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.14880 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.14880 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.14880 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.14880 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.